SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-005971
Filing Date
2024-05-10
Accepted
2024-05-10 16:46:03
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q edsa_10q.htm   iXBRL 10-Q 752950
2 CERTIFICATION edsa_ex311.htm EX-31.1 12768
3 CERTIFICATION edsa_ex312.htm EX-31.2 12839
4 CERTIFICATION edsa_ex321.htm EX-32.1 4421
5 CERTIFICATION edsa_ex322.htm EX-32.2 4397
  Complete submission text file 0001654954-24-005971.txt   3746496

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA edsa-20240331.xsd EX-101.SCH 44009
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20240331_lab.xml EX-101.LAB 233529
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20240331_cal.xml EX-101.CAL 36441
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20240331_pre.xml EX-101.PRE 201670
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20240331_def.xml EX-101.DEF 106199
66 EXTRACTED XBRL INSTANCE DOCUMENT edsa_10q_htm.xml XML 557467
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37619 | Film No.: 24935688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)